Loading…

Exploiting mesoporous silica nanoparticles as versatile drug carriers for several routes of administration

The exploitation of mesoporous silica nanoparticles (MSNs) as drug delivery systems has grown exponentially due to their remarkable tunable properties, such as high surface area, chemical and physical stability, high loading and release capacities, distinct possibilities of particle and pore structu...

Full description

Saved in:
Bibliographic Details
Published in:Microporous and mesoporous materials 2021-01, Vol.312, p.110774, Article 110774
Main Authors: Sábio, Rafael Miguel, Meneguin, Andréia Bagliotti, Martins dos Santos, Aline, Monteiro, Andreia Sofia, Chorilli, Marlus
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The exploitation of mesoporous silica nanoparticles (MSNs) as drug delivery systems has grown exponentially due to their remarkable tunable properties, such as high surface area, chemical and physical stability, high loading and release capacities, distinct possibilities of particle and pore structures, as well as good biocompatibility, biodegradability, and easy clearance. However, the main exposure routes that exploit MSNs qualities, namely intravenous, subcutaneous, intramuscular, intratumoral, ophthalmic, pulmonary, nasal, dermal, and oral administrations, have been underreported to date. In addition, a better understanding of these administration routes can contribute to the development of smart MSNs-based nanoplatforms with interesting properties, such as high stability in physiological media, specificity and efficacy in theranostic applications, and further clinical translations. This review highlights the advantages and challenges of the administration routes aforementioned regarding the MSNs as drug delivery systems. It also shows how their properties can influence the interaction with biological media, and consequently, their biocompatibility, biodistribution, and clearance mostly in pre-clinical assays, in order to contribute to further MSNs-based nanoplatform clinical translations. [Display omitted] •Better understanding of the administration routes can contribute to the development of smart MSNs-based nanoplatforms.•The main exposure routes that exploit MSNs qualities have been underreported to date.•Size, morphology, porosity, surface charge, and modification influence biological behavior of MSNs.•Multifunctional MSNs are amazing drug delivery platforms for therapeutic purposes.
ISSN:1387-1811
1873-3093
DOI:10.1016/j.micromeso.2020.110774